A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment - UTU Research Portal

Go to Header Go to Navigation Go to Content Go to Footer

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment

: Åivo Julia, Lindström BM, Soilu-Hänninen M

: 2012

: 2090-2654

DOI: https://doi.org/10.1155/2012/802796